Optimizing safety surveillance for COVID-19 vaccines

Nat Rev Immunol. 2020 Aug;20(8):451-452. doi: 10.1038/s41577-020-0372-8.


Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to propel vaccine safety monitoring into the twenty-first century.

Publication types

  • Review

MeSH terms

  • Betacoronavirus / immunology*
  • COVID-19
  • COVID-19 Vaccines
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / prevention & control
  • Humans
  • Immunologic Surveillance / immunology*
  • Pandemics
  • Pneumonia, Viral / immunology*
  • SARS-CoV-2
  • Safety
  • Viral Vaccines / adverse effects*
  • Viral Vaccines / immunology*


  • COVID-19 Vaccines
  • Viral Vaccines